Dorothy B. Abel and Aditi Upadhye, RAC, review the FDA’s Early Feasibility Study Program’s evolution, key guiding principles, and its role in supporting earlier access to innovative medical device technologies while maintaining patient safety. evtoday.com/articles/2026-ma…
Dr. Jeffrey G. Carr reviews the 2026 revision of CPT codes for lower extremity revascularization, highlighting key updates and illustrating how they are applied in a real-world CLTI case. #Sponsored by @Medtronicevtoday.com/articles/2026-ma…
Chrissy van Wely, MD; Rens J. Oosterveld, MD; Lieke C.D. Brugman, MSc; Ozan Yazar, MD; & Lee H. Bouwman, MD, offer practical guidance outlining the benefits, limitations, & technical considerations of using OCT in BTK treatment. evtoday.com/articles/2026-ma…
Dr. Peter Schneider and Paul Wilson discuss the recent successful completion of FIH cases with the Serranator® SONIC IVL System and the closing of an oversubscribed $41 million Series D financing | #Sponsored by @CagentVascularevtoday.com/articles/2026-ma…
An interview with Misti Malone, PhD, & Donna Buckley, MD, from the FDA provides insight into modern lower-extremity revascularization trials, including evolving endpoint definitions, the advantages & limitations of adaptive trial designs, & more. evtoday.com/articles/2026-ma…
Drs. @bryce_yolanda, @EdwardChoke, Andrew Holden, and Bruno Migliara focus on key decisions and techniques for successful bailout, including when to pivot, how to escalate, and which strategies are most effective in complex CTO interventions. evtoday.com/articles/2026-ma…
Michael Strong, MA; Matthew Menard, MD; Alik Farber, MD; & @krosenfieldMD, discuss outcomes from substudies of the @BEST_CLI trial, with these analyses providing greater clarity on which patients may benefit most from a surgical vs endovascular approach. evtoday.com/articles/2026-ma…